QI Banner

 
 

 

 

 

Publications - Bibliography

J.H. Coggin, Jr., Enhanced Virus Transformation of Hamster Embryo Cells In Vitro, J. Virol. 3:458-462 (1969).

Coggin, Jr., J. H., Ambrose, K. R., and Anderson, N. G. Fetal Antigen Capable of Inducing Transplantation Immunity Against SV40 Hamster Tumor Cells. J. Immunol. 105:524-526 (1971).

Coggin, Jr., J. H., Ambrose, K. R., Bellomy, B. B. and Anderson, N. G. Tumor Immunity in Hamster Immunized with Fetal Tissue. J. Immuno. 107:526-533 (1971)

Ambrose, K. R., Anderson, N. G. and Coggin, Jr., J. H. Interruption of SV40 Oncogenesis with Human Fetal Antigen. Nature 233:194-195 (1971).

Girardi, A. J., Reppucci, P., Dierlam, P., Rutala, W., and Coggin, Jr., J. H. Prevention of Simian Virus 40 Tumors by Hamster Fetal Tissue: Influence of Parity Status of Donor Females on Immunogenicity of Fetal Tissue and on Immune Cell Cytotoxicity. Proc. Nat'l. Acad. Sci. 70(1):183-186 (1973).

Coggin, Jr., J. H., Ambrose, K. R., Dierlam, P. L., and Anderson, N. G. Proposed Mechanisms by Which Autochthonous Tumors Escape Immune Rejection. Cancer Res. 34:2092-2101 (1974).

Coggin, Jr., J. H. and Anderson, N. G. Cancer, Differentiation, and Embryonic Antigens: Some Central Problems. Adv. Cancer Res. 19:105-165 (1974).

Coggin, Jr., J. H. and Ambrose, K. R. Embryonic and Fetal Determinants on Virally and Chemically Induced Tumors. In Methods in Cancer Research, Harris Busch (ed.), 18, pp. 371-389, Academic Press, New York (1979).

Coggin, Jr., J. H. Comparison of SV40 Induced Mouse and Hamster Tumor Specific Transplantation Antigen. J. Nat'l. Cancer Inst. 63:1029-1034 (1979).

Coggin, Jr., J. H. Induction of Transplantation Resistance with Soluble Simian Virus 40-induced Hamster Tumor-specific Transplantation Antigen. Cancer Research. 39:2952-2959 (1979).

Coggin, Jr., J. H., Adkison, L., and Anderson, N. G. Fetal Antigens Shared as Transplantation Rejection Antigens on Chemically Induced Mouse and Hamster Sarcomas. Cancer Res. 40:1568-1573 (1980).

Weppner, W. A. and Coggin, Jr., J. H. Virus Induced Cellular Immunity to Simian Virus 40 Tumor-specific Surface Antigens in Adult Hamsters. J. Natl. Cancer Inst. 64:757-763 (1980).

Weppner, W. A. and Coggin, Jr., J. H. Antigenic Similarity Between Plasma Membrane Proteins of Fetal Hamster Cells and Simian Virus 40 Tumor Specific Surface Antigens. Cancer Res. 40:1380-1387 (1980).

Weppner, W. A. and Coggin, Jr., J. H. Regulation of Hamster Lymphocyte Reactivity to Concanavalin A. Cell. Immunol. 54(1):193-202 (1980).

Coggin, Jr., J.H. Embryonic Antigens in Malignancy and Pregnancy: Common Denominators in Immune Regulation, 1983 Fetal Antigens and Cancer, Pittman, London (Ciba Foundation Symposium 96), p. 28-54.

Coggin, Jr., J. H., Gillis, L. D. and Payne, Jr., W. J. Differential Extraction of Tumor Specific Transplantation Antigen and Embryonic Antigen from SV40- and Adenovirus 7-Induced Sarcoma Cells of Hamsters with 1-Butanol and 3-M KCl. J. Natl. Cancer Inst. 72:853-862 (1984).

Payne, W. J. and Coggin, Jr., J. H. Mouse Monoclonal Antibody to Embryonic Antigen: Development, Cross-reactivity with Rodent and Human Tumors and Preliminary Polypeptide Characterization. J. Natl. Cancer Inst. 75(3):115-132 (1985).

Coggin, Jr., J. H. Oncofetal Antigens. Nature 319:428 (1986).

Coggin, Jr., J.H., Rohrer, S.D., Leinbach, E.D., Hester, R.B., Liu, P.I., and Heath, L.S. Radiation-induced Lymphoblastic Lymphomas/Leukemias and Sarcomas of Mice Express Conserved, Immunogenic 44 Kilodalton Oncofetal Antigen. Amer. J. Pathol. 130(1):136-146 (1988).

Gussack, G.S., Rohrer, S.D., Hester, R.B., Liu, P.I., and Coggin, Jr., J.H. Human Squamous Cell Carcinoma Lines Express Oncofetal 44 kD Polypeptide Defined by Monoclonal Antibody to Mouse Fetus. Cancer 62:57-64 (1988).

R.B. Hester, S.D. Rohrer, P.I. Liu, and J.H. Coggin, Jr. Differential expression of class I MHC determinants by lymphoblastic leukemia/lymphoma cell lines. JNCI 82:1209-1214 (1990).

R.B. Hester and J.H. Coggin, Jr. Tumorigenic sublethal whole-body X-irradiation of RFM mice enhances cell-mediated cytotoxicity while transiently depressing T- and B-lymphocytes. Molecular Biotherapy. 1(5):244 (1989).

A.L. Barsoum and J.H. Coggin, Jr. Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice. Journal of Biological Response Modifiers. 8:579-592 (1989).

R.B. Hester, S.D. Rohrer, P.I. Liu, and J.H. Coggin, Jr. Differential expression of class I MHC determinants by lymphoblastic leukemia/lymphoma cell lines. JNCI 82:1209-1214 (1990).

Barsoum, A. and Coggin, J., Jr. Isolation and partial characterization of a soluble oncofetal antigen from murine and human amniotic fluids. Inter. J. Cancer 48:248-252 (1991).

Rohrer, S., Sarli, R., Barsoum, A., Hester, R., and Coggin, J., Jr. Expression of 44 Kilodalton Oncofetal Antigen as a Premalignancy Marker in X Irradiation Induced Murine T-Cell Lymphoma JNCI, 84:602-609 (1992).

Barsoum, A. and Coggin, J., Jr. Isolation and characterization of 200kD oncofetal antigen from radiation induced murine lymphoma tumors. Int. J. Biochem. 24, 483-489 (1993).

Coggin, J., Rohrer, S, Hester, R., Barsoum, A., Rashid, H., and Gussack, G. 44-kD oncofetal transplantation antigen in rodent and human fetal cells: implications of recrudescence in human and rodent cancers. Archives of Otolaryngology-Head and Neck Surgery, 119: 1257-1266. 1993

Rohrer, J.W., Rohrer, S.D., Barsoum, A.L. and Coggin, Jr, J.H. Differential recognition of murine tumor associated oncofetal transplantation antigen and individually specific tumor transplantion antigens by syngeneic cloned BALB/c and RFM mouse T cells. J. Immunol. 152: pp755-764 Jan. 15, 1994

Rashid, H-U., Barsoum, A.L., Cao, T. M., and Coggin, Jr., J.H. Isolation of partial DNA clones encoding a protein which has the characteristics of a unique oncofetal antigen conserved in rodent and human tumors and fetus. J.N.C.I. 86, 515-525, 1994

Coggin, J.H. Classification of tumor associated antigens in rodents and humans. Immunology Today: May, Vol. 15: 246-247, 1994.

Rohrer, J , Culpepper, C , Barsoum, A , and Coggin, J H. Characterization of RFM mouse T lymphocyte anti-OFA immunity in apparent tumor free, long term survivors of sub-lethal X-irradiation by limiting dilution T lymphocyte cloning. J. of Immunology, 154: 2266-2280, 1995.

Coggin, J.H., Jr., Barsoum, A., and Rohrer, J. 1999. Tumors express both unique TSTA and crossprotective 44KDa oncofetal antigen. Immunol. Today 19: 405-408 [Viewpoint].

Rohrer J. W., A. L. Barsoum, D. L. Dyess, J. A. Tucker and J. H. Coggin, Jr. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes. J. Immunol. 162: 6880-6892, 1999.

Coggin J. H., Jr., A. L. Barsoum and J. W. Rohrer. 37 Kilodalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogen on primary rodent and human cancers. Anticancer Res. 19: 5535-5542, 1999.

Barsoum A. L., J. W. Rohrer and J. H. Coggin, Jr. 37kDa oncofetal antigen is an autoimmunogenic homologue of the 37kDa laminin receptor precursor. Cellular & Molecular Biology Letters 5: 207-203, 2000.

Rohrer J. W., A. L. Barsoum and J. H. Coggin, Jr. The development of a new universal tumor rejection antigen expressed on human and rodent cancers for vaccination and prevention of cancer and in anti-tumor therapy. Mod. Aspects of Immunobiol. 1, 191-195, 2001.

Zelle-Rieser C., A. L. Barsoum, F. Sallusto, R. Ramoner, J.W. Rohrer, Lorenz Höltel, G. Bartsch, J. H. Coggin Jr. and M. Thurnher. Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma. J. Urol. 165, 1705-1709, 2001.

Coggin J. H., Jr., A. L. Barsoum, J.W. Rohrer, J. A. Tucker, and D. L. Dyess Materno-fetal immunobiology hypothesis: immature laminin receptor protein is a primitive, species conserved, universal embryonic T and B cell immunogen providing both maternal and fetal protection. Mod. Aspects of Immunobiol. 2 (2) 84-91, 2001.

Höltl L., C. Zelle-Rieser, H. Gander, C. Papesh, R. Ramoner, G. Bartsch, H. Rogatsch, A. L. Barsoum, Joseph H. Coggin, Jr. and Martin Thurnher. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin. Cancer Res. 8 (11) 3369-3376, 2002.

Siegel S, A. Wagner, D. Kabelitz, M. Marget, J. Coggin Jr., A. Barsoum, J. Rohrer, N. Schmitz, and M. Zeis. Induction of cytotoxic T cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematological malignancies. Blood 102, 4416-4423, 2003.

Coggin J. H. Jr, J. W. Rohrer, and A. L. Barsoum. True immunogenicity of oncofetal antigen/immature laminin receptor protein. Cancer Res. 64, 4685, 2004

Coggin J. H. Jr., A.L. Barsoum, J. W. Rohrer, M. Thurnher and M. Zeis. Contemporary definitions of tumor specific antigens, immunogens, and markers as related to the adaptive responses of the cancer-bearing host. Anticancer Res. 25, 2345-2356, 2005

Coggin J. H. Jr., A. L. Barsoum, J. W. Rohrer, M.Thurnher, M. Zeis and P.O. Schwarzenberger. Cancer Vaccine Technology Update: The immunobiology of 37 kDa Oncofetal Antigen/Immature Laminin Receptor Protein (OFA/iLRP) and RNA, a universal tumor immunogen. Mod. Asp. Immunobiol. 16, 27-34, 2005.

Rohrer, J. W., A. L. Barsoum, and J. H. Coggin, Jr. 2006. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones. J. Immunol. 176:2844.

Siegel, S., A. Wagner, B. Friedrichs, Anneke Wendeler, L. Wendel, D. Kabelitz, J. Steinmann, A. Barsoum, J. Coggin, J. Rohrer, P. Dreger, N. Schmitz, and M. Zeis. 2006. Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies. J. Immunol. 176:6935.

Adel L. Barsoum, Bainan Liu, James W. Rohrer, Joseph H. Coggin, Jr., J. Allan Tucker, Lewis K. Pannell, Paul O. Schwarzenberger. 2009. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein. Biomaterials (2009), doi:10.1016/j.biomaterials.2009.02.022